# newdrugapprovals.org

newdrugapprovals.org traffic: 11.66K visits in Sep 2026

newdrugapprovals.org had about 11.66K visits in September 2026, up 20.40% from August; the top source is search.

Report updated 2026-09-01

## How much traffic does newdrugapprovals.org get?

- Estimated monthly visits: 11.66K (2026-09)
- MoM: +20.40%
- Global rank: 1,982,865
- Country rank · United States: 1,055,457
- Average visit duration: 00:19
- Pages per visit: 1.67
- Bounce rate: 46.07%
- Search share: 33.7%

## Where does newdrugapprovals.org's traffic come from?

- Direct: 30.3%
- Display ads: 8.8%
- Email: 3.4%
- Generative AI: 2.1%
- Other: 2.5%
- Referrals: 8.0%
- Search: 33.7%
- Paid search: 4.2%
- Social: 7.0%

## Which countries visit newdrugapprovals.org?

- United States: 35.7%
- India: 25.7%
- Vietnam: 23.3%
- Canada: 10.7%
- Japan: 2.6%

## What keywords send traffic to newdrugapprovals.org?

- why is rebamipide not fda approved: Estimated visits 210, Monthly searches 220
- tagoor laboratories tegoprazan process: Estimated visits 120
- durlobactam total synthesis: Estimated visits 110, Monthly searches 360
- palovarotene total synthesis: Estimated visits 110, Monthly searches 360
- vimseltinib synthesis: Estimated visits 110, Monthly searches 120

Canonical: https://vaneform.com/e/newdrugapprovals-org